018410895

YONJUSK

---

March 1, 2021

Trademark Summary

The trademark application YONJUSK was filed by Eli Lilly and Company, a U.S. corporation (the "Applicant"). The application was published for oppositions on May 24, 2021, and it was registered by office on August 30, 2021 without any oppositions.

The application was filed in English (German was selected as the second language).

---

Goods And Services

• The mark was filed in class 5 with following description of goods:
  
  1. Pharmaceutical preparations namely, pharmaceutical preparations for the treatment, prevention and/or diagnosis of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders
  2. Pharmaceutical preparations namely, pharmaceutical preparations for the treatment, prevention and/or diagnosis of headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders
  3. Pharmaceutical preparations namely, pharmaceutical preparations for the treatment, prevention and/or diagnosis of migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, ulcerative colitis
  4. Diagnostic agents and substances for medical purposes
  5. Radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain
  6. Pharmaceutical preparations.